UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000000853
Receipt number R000001024
Scientific Title Randomized control trial of Rabeprazole for prevention of aspirin-associated ulcers
Date of disclosure of the study information 2008/01/01
Last modified on 2008/09/22 11:14:44

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Randomized control trial of Rabeprazole for prevention of aspirin-associated ulcers

Acronym

Randomized control trial of Rabeprazole for prevention of aspirin-associated ulcers

Scientific Title

Randomized control trial of Rabeprazole for prevention of aspirin-associated ulcers

Scientific Title:Acronym

Randomized control trial of Rabeprazole for prevention of aspirin-associated ulcers

Region

Japan


Condition

Condition

Aspirin-associated ulcers

Classification by specialty

Medicine in general Gastroenterology Cardiology
Emergency medicine

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To assess the safety and efficacy of rabeprazole for prevention of aspirin associated gastroduodenal ulcers

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1

Confirmatory

Trial characteristics_2

Pragmatic

Developmental phase

Phase III


Assessment

Primary outcomes

Incidence of gastroduodenal ulcers

Key secondary outcomes

gastroduodenal mucosal damage assessed by modified Lanza's score
hemorrhagic gastroduodenal ulcer
symptoms asssessed by Gastrointestinal Symptoms Rating Scale


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Open -but assessor(s) are blinded

Control

No treatment

Stratification

YES

Dynamic allocation

YES

Institution consideration

Institution is not considered as adjustment factor.

Blocking

NO

Concealment

Central registration


Intervention

No. of arms

2

Purpose of intervention

Prevention

Type of intervention

Medicine

Interventions/Control_1

Rabeprazole
3 months
10mg/day
once per day

Interventions/Control_2

no treatment

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

Patients who is going to be introduced low-dose aspirin for more than four months

Key exclusion criteria

History of peptic ulcer diseases

Target sample size

100


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Keiji Ogura

Organization

University of Tokyo

Division name

Clinical Research Center

Zip code


Address

7-3-1 Hongo, Bunkyo-ku Tokyo

TEL

03-3815-5411

Email



Public contact

Name of contact person

1st name
Middle name
Last name Keiji Ogura

Organization

University of Tokyo

Division name

Clinical Research Center

Zip code


Address


TEL


Homepage URL


Email

keiji-tky@umin.ac.jp


Sponsor or person

Institute

University of Tokyo, Department of Gastroenterology

Institute

Department

Personal name



Funding Source

Organization

Department of Gastroenterology
University of Tokyo

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2008 Year 01 Month 01 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Date of protocol fixation

2007 Year 07 Month 26 Day

Date of IRB


Anticipated trial start date

2008 Year 04 Month 01 Day

Last follow-up date

2009 Year 12 Month 01 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2007 Year 10 Month 16 Day

Last modified on

2008 Year 09 Month 22 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000001024